SuperworthOppenheimer OPY
- Market cap
- $1.1B
- PE
- 11.4×
- 9y median 9.5×
- Forward PE
- n/m
- not a meaningful number
- Revenue, 12 months
- $1.8B
- +21% on a year ago
- Net margin
- 5.7%
Oppenheimer trades at 11.4× trailing earnings, pricier than 75% of the last ten years. Revenue was $1.8B over the last twelve months, up 21% on a year earlier with a 6% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $312.7M+6% | $308.3M−2% | $353.1M+10% | $330.6M+8% | $373.4M+19% | $375.4M+22% | $367.8M+4% | $373.2M+13% | $424.4M+14% | $472.6M+26% | $445.1M+21% | $454.9M+22% | |
| $41.3M+190% | $36.1M−12% | $58M+80% | $37.8M+556% | $59.5M+44% | $38.4M+7% | $62.8M+8% | $54.7M+45% | $54.1M−9% | $126.1M+228% | −$8.3M | $59.3M+8% | |
| Interest expense | $19.7M+181% | $18.2M+71% | $20.5M+56% | $22M+26% | $24.1M+22% | $21.4M+17% | $21.4M+4% | $22.5M+3% | $22.5M−7% | $20.1M−6% | $18.7M−13% | $19.9M−12% |
| Pre-tax income | $21.6M+198% | $17.8M−41% | $37.5M+97% | $15.9M | $35.4M+64% | $17.1M−4% | $41.4M+11% | $32.2M+103% | $31.6M−11% | $106M+521% | −$27M | $39.4M+23% |
| $7.8M+204% | $6.2M−21% | $11.7M+155% | $5.6M | $10.9M+39% | $6.3M+2% | $10.7M−9% | $10.5M+88% | $9.9M−9% | $32.1M+406% | −$6.4M | $12.1M+15% | |
| Net income | $13.9M+207% | $11.1M−51% | $26.1M+78% | $10.3M | $24.5M+77% | $10.7M−3% | $30.7M+18% | $21.7M+111% | $21.7M−11% | $74.4M+593% | −$20.6M | $27.4M+26% |
| $1.21+227% | $0.98−48% | $2.37+94% | $0.92 | $2.16+79% | $0.94−4% | $2.72+15% | $1.91+108% | $1.90−12% | $6.48+589% | −$1.93 | $2.38+25% | |
| 11.4M−6% | 11.3M−6% | 11M−8% | 11.1M+1% | 11.3M−1% | 11.4M+1% | 11.3M+3% | 11.3M+2% | 11.5M+2% | 11.5M+0% | 10.6M−6% | 11.5M+1% |
Operating income: 59 periods, Q2 FY10 to Q2 FY26: not printed by the filing, worked out from its own lines.
EPS, diluted: 7 periods, Q4 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 13 periods, Q4 FY10 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. 3 periods, Q4 FY12 to Q4 FY16: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Financial - Capital Markets nearest Oppenheimer's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| OPYOppenheimer | $1.1B | 11.4× | 9.5× | n/m | +21% | 5.7% | |
| WTWisdomTree | $3.2B | 40.8× | 21.9× | n/m | +37% | 13.3% | |
| MIAXMiami International | $3.4B | 39.1× | 46.1× | n/m | +17% | 9.7% | |
| PIPRPiper Sandler Companies | $4.6B | 15.0× | 20.6× | n/m | +32% | 14.5% | |
| MKTXMarketaxess | $5.8B | 19.4× | 49.3× | n/m | +4% | 35.2% | |
| VIRTVirtu Financial | $8.7B | 9.3× | 10.9× | n/m | +21% | 13.5% | |
| SFStifel Financial | $10.1B | 11.9× | 14.5× | n/m | +11% | 14.3% | |
| Peer median | $5.2B | 17.2× | 21.3× | n/a | +19% | 13.9% |
Investors who own it
Investors we follow who held Oppenheimer at the end of Jun 30, 2026, from their 13F filings.
- Polen CapitalPolen Capital0.0% of portfoliotrimmed
More on Oppenheimer
Each number over time
Where it ranks
Its groups
About
- Industry
- Financial - Capital Markets
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .